1. Medtech Insight

Abbott Inks Automated Insulin Platform Partnership With Insulet

 
• By Catherine Longworth

Abbott has signed a partnership with Insulet Corporation to create an integrated technology that automatically adjusts insulin delivery based on personalized glucose data.

SANTA CLARA, CA/USA - JULY 29, 2017: Abbott Laboratories exterior and logo. Abbott Laboratories is an American worldwide health care company. - Image

Abbott and Insulet Corporation are partnering to integrate glucose-sensing and automated delivery technologies, the companies announced 19 February.

The collaboration will combine Abbott's continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon Automated Insulin Delivery System to offer...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight

Inspection Readiness 101: Be Prepared To Avoid Common Pitfalls When The FDA Comes Knocking

 
• By Brian Bossetta

A panel of regulatory pros offered stakeholders tips for avoiding FDA citations after facility inspections. The July 29 webinar, hosted by ProPharma and Hyman Phelps and McNamara, follows the agency’s May announcement that it plans to up random foreign inspections.

Execs On The Move: July 21–25, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Biostate AI Builds Global RNA-AI Pipeline With $12M Boost, Ventures In China And India

 
• By Shubham Singh

Biostate AI has set up an Indian subsidiary, Bayosthiti, to develop cancer and cardiac diagnostics with local hospitals. This follows a joint venture with China's Kindstar Global and mirrors Biostate’s US collaboration with Mass General Brigham to build AI models for melanoma.